BioSpyder Awarded 5-Year EPA Contract With a Maximum Value of $25 Million to Perform High-Throughput Genetic Toxicology Screening

Faster, Cheaper, Better – TempO-Seq® Assay Establishes Itself as a Leading Gene Expression Profiling Tool Press Release – updated: Jul 1, 2020 CARLSBAD, Calif., July 1, 2020 (Newswire.com)…

Read more BioSpyder Awarded 5-Year EPA Contract With a Maximum Value of $25 Million to Perform High-Throughput Genetic Toxicology Screening